TEDA BIOMEDICAL (08189) released its annual performance with a net loss of 90.82 million yuan attributable to shareholders, an increase of 226.67% year-on-year.

00:10 01/04/2026

Taidea Biotech (08189) released its annual performance up to December 31, 2025. The group's revenue was 523 million yuan, an increase of 35.67% year-on-year. Shareholders' attributable loss was 90.82 million yuan, an increase of 226.67% year-on-year, with a loss per share of 4.37 cents.

TEDA BIOMEDICAL (08189) announced its annual performance up to December 31, 2025. The group's revenue was 523 million RMB, a year-on-year increase of 35.67%. Shareholders' net loss was 90.82 million RMB, an increase of 226.67% compared to the previous year. Loss per share was 4.37 cents.

LINK HOLDINGS (08237) released its annual financial performance, with a net profit attributable to shareholders of HK$178 million, turning a loss into profit compared with the previous year.

JISHENG GP HLDG (08133) announces financial results for 2025 with a net loss attributable to owners of the company of HK$3.977 million, representing a year-on-year increase of approximately 1.05 times.

ZIJING INTL FIN (08340) announces annual performance with a shareholder loss of 7.437 million Hong Kong dollars, a year-on-year increase of 200.24%.

LINK HOLDINGS (08237) released its annual financial performance, with a net profit attributable to shareholders of HK$178 million, turning a loss into profit compared with the previous year.

ZIJING INTL FIN (08340) announces annual performance with a shareholder loss of 7.437 million Hong Kong dollars, a year-on-year increase of 200.24%.